Home
  • English
  • Deutsch
FENS Forum 2026
Neuroforum 2025 Issue 1
FENS

Prof. Dr. Birgit Liss

Home / Node / Prof. Dr. Birgit Liss

zurück zur Übersicht

Prof. Dr. Birgit Liss

Kandidatin Sektionssprecherin "Zelluläre Neurowissenschaften"

Universität Ulm
Medizinische Fakultät
Institute für Angewandte Physiologie,
Albert-Einstein-Allee 11
89081 Ulm
Tel.: +49 731 500 - 36200 / - 36214 (PA)
Email: birgit.liss@uni-ulm.de
Homepage: https://www.uni-ulm.de/med/angewphys/

 

 Baumann/all4foto.de

Curriculum Vitae

Geburtsdatum 29.04.1971 in Flensburg, Germany


Education and Affiliations

09.1995 Diploma (M.Sc.) in Biochemistry & Molecular Biology (Major: Neuroscience)
University of Hamburg, Germany
01.1996-04.1999 Graduate student, Center for Molecular Neurobiology Hamburg, ZMNH (Prof. O. Pongs) & Zoological Institute, Hamburg University, Germany (Supervisor Prof. M. Gewecke)
04.1999 Graduation, Dr. rer. nat. (PhD), University of Hamburg, Germany
05.1999-09.2001 Postdoctorate, Laboratory of Physiology (Prof. FM. Ashcroft), and MRC ANU (Prof. P. Somogyi), University of Oxford, UK
10.2001-01.2003 Royal Society Dorothy Hodgkin Research Fellow, Laboratories of Pharmacology and Physiology, University of Oxford, UK
02.2003-03.2007 Junior-Professor for Neurophysiology (tenure-track C2/C3),
Institute for Physiology (Prof. J. Daut), Marburg University, Germany
04.07-08.2010 Full Professor (W3), Institute for General Physiology (Prof. P. Dietl).
University of Ulm, Germany
Since 09.2010 Director, Institute of Applied Physiology, University of Ulm, Germany
Since 01.2019 Visiting Fellow / Guest Professor (no teaching obligation),            New College and Linacre College, University of Oxford, UK
11.2020-03.2022 Elected Fellow of the HIAS (Hamburg Institute for Advanced Study) Wissenschaftskolleg


Selected Postgraduate Stipends & Awards / Honours

1999-2000                 Blaschko Visiting Research Fellowship & Cephalosporin Junior Research Fellowship, Linacre College, Oxford University, UK
2000-2003 Todd-Bird Biochemistry Junior Research Fellowship, New College, Oxford University, UK
2001-2005 Royal Society Dorothy Hodgkin Research Fellowship, Oxford University, UK
2006 German Brain Research Society Award (Hirnliga-Preis)
2007 Alfried Krupp Prize for young University Professors in Germany


Selected Academic Functions / Boards

Since 2009 Board Member: Excellence at German Universities (Head: E. Bulmahn)
Since 2016 Scientific Advisory Board: Oxford Parkinson’s disease Centre OPDC
2016-2019 Board of Directors: Deutsche Physiologische Gesellschaft (DPG)
Since 2017 Scientific Advisory Board: Alfried Krupp Foundation
2019 President & Chair of the 98th joint meeting of the German Physiological Society in Ulm (http://www.dpg2019.de)
Since 2019 Board Member: Kommission zur Weiterentwicklung kompetenzorientierter Gegenstandskataloge, NKLM
Since 2020 Board Member: Kontroll- und Überprüfungskommission,                  Institut für medizinische und pharmazeutische Prüfungsfragen (IMPP)

Reviewer:

Grants DFG, DAAD, Welcome Trust, FWF, Krupp, and other
Journals   Nature Commun, PNAS, Brain, Cell Rep, NAR, J. Neurosci, J Neurochem etc.


 

Selected publications

Main research areas: ion channels, receptors & transporters, Ca2+ signalling, dopaminergic system, aging, neurodegenerative disease, cellular & systemic neuroscience.
All publications downloadable as PDF: https://www.uni-ulm.de/med/angewphys/forschung/liss/publikationen/

  •  Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J, Simons C, Patil K, Mannal N, Dragicevic E, Spaich D, Mueller S, Nemeth J, Hollmann H, Deuter N, Mousba Y, Kubisch C, Poetschke C, Striessnig J, Pongs O, Schneider T, Wade-Martins R, Patel S, Parlato R, Frank T, Kloppenburg P, Liss B (2019): Cav2.3 channels trigger selective dopaminergic neuron loss in Parkinson’s disease. Nature Commun 10:5094.
  • Simons C, Benkert J, Deuter N, Poetschke C, Schneider T, Duda J, Liss B (2019): NCS-1 deficiency affects mRNA-levels of genes involved in regulation of ATP-Synthesis and mitochondrial stress in highly vulnerable Substantia nigra dopaminergic neurons. Frontiers Mol Neurosci, 12:252
  • Liss B and Striessnig J (2019): L-Type Calcium Channels a Drug Target for Neuroprotective Therapy in Parkinson Disease. Annu Rev Pharmacol Toxicol, 59:20.1-20.27.
  • Grimm CM, Aksamaz S, Schulz S, Teutsch J, Sicinski P, Liss B, Kätzel D (2018): Schizophrenia-related cognitive dysfunction in the Cyclin-D2 knockout mouse model of ventral hippocampal hyperactivity. Transl Psychiatry. 8(1):212.
  • Krabbe S, Duda J, Schiemann J, Poetschke C, Schneider G, Kandel ER, Liss B, Roeper J, Simpson EH (2015): Increased Dopamine D2 Receptor Activity in the Striatum Alters the Firing Rate and Burst Activity of Dopamine Neurons in the Ventral Tegmental Area. PNAS, 112(12):E1498-506.  IF: 10.8.
  • Dragicevic E, Poetschke C, Duda J, Schlaudraff F, Lammel S, Schiemann J, Fauler M, Hetzel A, Watanabe M, Lujan R, Malenka RC, Striessnig J, Liss B (2014): Cav1.3 channels control D2-autoreceptor responses via NCS-1 in Substantia Nigra dopamine neurons. Brain, 137(8):2287-302.
  • Schlaudraff F, Grundemann J, Fauler M, Dragicevic E, Hardy J, Liss B (2014): Orchestrated increase of dopamine and PARK mRNAs but not miR-133b in dopamine neurons in Parkinson's disease. Neurobiol Aging, 35:2302-15.
  • Schiemann J, Schlaudraff F, Klose V, Bingmer M, Seino S, Magill P, Zaghloul K, Schneider G, Liss B+, Roeper J+ (2012):. ⦁    K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat Neurosci, 15(9):1272-80.
  • Sperka T, Song Z, Morita Y, Nalapareddy K, Guachalla LM, Lechel A, Begus-Nahrmann Y, Burkhalter MD, Mach M, Schlaudraff F, Liss B, Ju Z, Speicher MR, Rudolph KL. (2011): Puma and p21 represent cooperating checkpoints limiting self-renewal and chromosomal instability of somatic stem cells in response to telomere dysfunction. Nat Cell Biol, 14(1):73-9.